Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 1.26B | £ 1.39B | £ 1.44B | £ 1.79B | £ 1.57B |
Total Assets | £ 9.81B | £ 9.56B | £ 8.12B | £ 8.03B | £ 7.66B |
Total Debt | £ 2.57B | £ 2.34B | £ 2.05B | £ 2.09B | £ 2.21B |
Net Debt | £ 1.31B | £ 943.58M | £ 614.01M | £ 301.53M | £ 639.85M |
Total Liabilities | £ 6.73B | £ 6.59B | £ 5.32B | £ 5.33B | £ 5.06B |
Stockholders Equity | £ 3.01B | £ 2.91B | £ 2.73B | £ 2.65B | £ 2.54B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |